EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The muscle-brain axis in type 2 diabetes: Molecular pathways linking sarcopenia and cognitive decline

Dionysios Xenos, Francesca Mancinetti, Patrizia Mecocci, Virginia Boccardi

Ageing Research Reviews · 2026

DOI: 10.1016/j.arr.2025.102955 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026. Verfasst von Dionysios Xenos und 3 weiteren Autor:innen. Beteiligte Einrichtung: Regional Experts Center for Dementia, Division of Geriatrics, Nuovo Regina Margherita Hospital Unit, Rome, Italy. Hauptthemen laut MEDLINE: Sarcopenia, Diabetes Mellitus, Type 2, Cognitive Dysfunction, Brain. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus (T2DM) is increasingly recognized as a shared pathological substrate for both sarcopenia and cognitive decline, particularly Alzheimer's disease (AD). This review synthesizes current evidence on the converging molecular pathways linking insulin resistance, hyperglycaemia, mitochondrial dysfunction, oxidative stress, and chronic inflammation to muscle wasting and neurodegeneration. Central to this interplay is the muscle-brain axis, a bidirectional communication network mediated by myokines, exercise-induced cytokines that influence metabolic and neural homeostasis. Key myokines such as IGF-1, irisin, BDNF, FGF21, and SPARC promote myogenesis, synaptic plasticity, and neuroprotection, while others including myostatin, IL-8, and GDF-15 exert detrimental effects. Context-dependent molecules such as IL-6, IL-15, lactate, and cathepsin-B show dual roles modulated by aging, inflammation, and metabolic state. Emerging data support that improved glycaemic control, enhanced insulin sensitivity, and sustained physical activity can attenuate both sarcopenia and cognitive decline. This review aims to summarize current evidence describing how insulin resistance, chronic hyperglycaemia, mitochondrial dysfunction, oxidative stress, and inflammation interact to promote both muscle wasting and neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaDiabetes Mellitus, Type 2Cognitive DysfunctionBrainMuscle, SkeletalHumansInsulin ResistanceAnimalsOxidative Stress

Stichwörter der Autor:innen

BrainDiabetesMuscleMyokinesSarcopenia

Autor:innen und Institutionen

  • Regional Experts Center for Dementia, Division of Geriatrics, Nuovo Regina Margherita Hospital Unit, Rome, Italy.
  • Division of Gerontology and Geriatrics, Department of Medicine and Surgery, University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy.
  • Division of Gerontology and Geriatrics, Department of Medicine and Surgery, University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy; Division of Clinical Geriatrics, NVS Department, Karolinska Ins…
  • Division of Gerontology and Geriatrics, Department of Medicine and Surgery, University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy. Electronic address: virginia.boccardi@unipg.it.

Zitieren

APA

Xenos, D., Mancinetti, F., Mecocci, P., & Boccardi, V. (2026). The muscle-brain axis in type 2 diabetes: Molecular pathways linking sarcopenia and cognitive decline. Ageing Research Reviews. https://doi.org/10.1016/j.arr.2025.102955

Vancouver

Xenos D, Mancinetti F, Mecocci P, Boccardi V. The muscle-brain axis in type 2 diabetes: Molecular pathways linking sarcopenia and cognitive decline. Ageing Research Reviews. 2026. doi:10.1016/j.arr.2025.102955

BibTeX
@article{Xenos2026,
  author = {Xenos, Dionysios and Mancinetti, Francesca and Mecocci, Patrizia and Boccardi, Virginia},
  title = {The muscle-brain axis in type 2 diabetes: Molecular pathways linking sarcopenia and cognitive decline},
  journal = {Ageing Research Reviews},
  year = {2026},
  doi = {10.1016/j.arr.2025.102955}
}
Kostenlos starten →